Zolmitriptan
| Use attributes for filter ! | |
| Molar mass | 287. 357 g/mol |
|---|---|
| CAS ID | 139264-17-8 |
| Formula | C16H21N3O2 |
| Trade name | Zomig, others |
| Elimination half-life | 3 hours |
| Metabolism | Hepatic (CYP1A2-mediated, to active metabolite) |
| Music groups | Sumatriptan |
| Rizatriptan | |
| Eletriptan | |
| Date of Reg. | |
| Date of Upd. | |
| ID | 2952903 |
About Zolmitriptan
Zolmitriptan, sold under the brand name Zomig among others, is a triptan used in the acute treatment of migraine attacks with or without aura and cluster headaches. It is a selective serotonin receptor agonist of the 1B and 1D subtypes. It was patented in 1990 and approved for medical use in 1997.